Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : KZR save search
Everest Medicines Announces Acceptance of VELSIPITY® New Drug Application in Macau
Published: 2024-03-11 (Crawled : 01:00) - prnewswire.com
KZR | $0.8016 -2.95% -3.04% 420K
|
Health Technology
|
| O: 0.01%
H: 1.22%
C: -0.28%
velsipity drug application
Everest Medicines to Announce Full-Year 2023 Financial Results on March 28, 2024
Published: 2024-03-06 (Crawled : 01:00) - prnewswire.com
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
|
| O: 3.14%
H: 1.49%
C: 1.08%
KZR | $0.8016 -2.95% -3.04% 420K
|
Health Technology
|
| O: 1.94%
H: 0.0%
C: -1.9%
financial results
Everest Medicines and Kezar Life Sciences Receive IND Approval from China NMPA for PALIZADE Trial in Lupus Nephritis
Published: 2024-02-26 (Crawled : 00:00) - biospace.com/
KZR | $0.8016 -2.95% -3.04% 420K
|
Health Technology
|
| O: 1.09%
H: 3.74%
C: -1.52%
lupus life approval sciences trial china
NKF Launches Educational 'Animated Video Series for Patients with Lupus and Lupus Nephritis'
Published: 2023-12-04 (Crawled : 17:00) - prnewswire.com
KZR | $0.8016 -2.95% -3.04% 420K
|
Health Technology
|
| O: 0.23%
H: 2.71%
C: 2.67%
lupus series
Kezar Life Sciences to Present at the 6th Annual Evercore ISI HealthCONx Conference
Published: 2023-11-21 (Crawled : 00:00) - biospace.com/
KZR | $0.8016 -2.95% -3.04% 420K
|
Health Technology
|
| O: -1.64%
H: 3.38%
C: 1.08%
conference life sciences
Cough-assisted Devices Global Market to Register Incremental Growth at a CAGR of ~7% by 2028 | DelveInsight
Published: 2023-08-16 (Crawled : 21:00) - prnewswire.com
NRSN | News | $1.33 -2.21% -2.26% 130K
|
|
| O: 0.01%
H: 1.56%
C: -3.29%
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: 2.95%
H: 0.0%
C: 0.0%
PHG | News | $20.97 -0.19% 0.0% 650K
|
Health Technology
|
| O: 5.99%
H: 0.0%
C: -2.07%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 1.89%
H: 0.0%
C: 0.0%
KZR | $0.8016 -2.95% -3.04% 420K
|
Health Technology
|
| O: -1.38%
H: 1.4%
C: -2.8%
DNLI | $15.55 -3.48% -3.6% 940K
|
Health Technology
|
| O: -0.13%
H: 0.72%
C: -2.64%
APLS G | $49.84 2.3% 2.25% 1.2M
|
Health Technology
|
| O: -4.15%
H: 0.0%
C: 0.0%
ANNX | $4.44 0.0% 3.3M
|
Health Technology
|
| O: 0.0%
H: 8.3%
C: 7.22%
global growth market
Kezar Life Sciences Reports Second Quarter 2023 Financial Results and Provides Business Update
Published: 2023-08-10 (Crawled : 23:00) - biospace.com/
KZR | $0.8016 -2.95% -3.04% 420K
|
Health Technology
|
| O: 0.0%
H: 3.48%
C: 1.99%
business life update sciences financial results
Inflammatory Myositis Market to Accelerate Substantially at a CAGR of 11.7% by 2032, Predicts DelveInsight
Published: 2023-07-18 (Crawled : 21:00) - prnewswire.com
KZR | $0.8016 -2.95% -3.04% 420K
|
Health Technology
|
| O: -0.42%
H: 3.4%
C: 1.7%
GLPG | News | $28.78 -2.28% -2.33% 140K
|
Health Technology
|
| O: 1.55%
H: 0.16%
C: -1.14%
market
Kezar Life Sciences to Participate in the Jefferies Healthcare Conference
Published: 2023-05-31 (Crawled : 12:01) - biospace.com/
KZR | $0.8016 -2.95% -3.04% 420K
|
Health Technology
|
| O: 0.35%
H: 4.9%
C: -2.8%
conference life sciences
Kezar Life Sciences to Change Virtual R&D Day Date to March 15, 2023
Published: 2023-03-13 (Crawled : 12:00) - biospace.com/
KZR | $0.8016 -2.95% -3.04% 420K
|
Health Technology
|
| O: 0.22%
H: 12.69%
C: 10.75%
day sciences change life
Kezar Life Sciences to Host Virtual R&D Day on March 22, 2023
Published: 2023-03-06 (Crawled : 13:00) - biospace.com/
KZR | $0.8016 -2.95% -3.04% 420K
|
Health Technology
|
| O: -1.06%
H: 4.83%
C: 2.86%
day sciences life
Kezar Life Sciences to Present at the 41st Annual J.P. Morgan Healthcare Conference
Published: 2023-01-04 (Crawled : 23:00) - biospace.com/
KZR | $0.8016 -2.95% -3.04% 420K
|
Health Technology
|
| O: 0.0%
H: 5.12%
C: 3.75%
sciences conference life
Kezar Life Sciences Presents Positive Complete Results from the MISSION Phase 2 Trial Evaluating Zetomipzomib in Lupus Nephritis at the American College of Rheumatology Convergence 2022
Published: 2022-11-14 (Crawled : 12:20) - biospace.com/
KZR | $0.8016 -2.95% -3.04% 420K
|
Health Technology
|
| O: 0.13%
H: 8.13%
C: 4.46%
sciences lupus life trial positive results
Kezar Life Sciences Presents Positive Complete Results from the MISSION Phase 2 Trial Evaluating Zetomipzomib in Lupus Nephritis at ASN’s Kidney Week 2022 Annual Meeting
Published: 2022-11-03 (Crawled : 15:00) - biospace.com/
KZR | $0.8016 -2.95% -3.04% 420K
|
Health Technology
|
| O: -1.63%
H: 3.45%
C: -1.52%
sciences meeting lupus life kidney week trial positive results
Kezar Life Sciences to Present Complete Results from the Phase 2 MISSION Trial of Zetomipzomib in Patients with Lupus Nephritis at the American Society of Nephrology’s Kidney Week 2022 Annual Meeting
Published: 2022-10-14 (Crawled : 15:20) - biospace.com/
KZR | $0.8016 -2.95% -3.04% 420K
|
Health Technology
|
| O: 0.36%
H: 1.8%
C: 0.0%
sciences meeting lupus life kidney week trial results
Kezar Life Sciences Reports Second Quarter 2022 Financial Results and Provides Business Update
Published: 2022-08-11 (Crawled : 01:00) - biospace.com/
KZR | $0.8016 -2.95% -3.04% 420K
|
Health Technology
|
| O: 0.7%
H: 2.47%
C: -3.46%
sciences life update results
Kezar Life Sciences Announces Positive Topline Results from the MISSION Phase 2 Trial Evaluating Zetomipzomib for the Treatment of Patients with Lupus Nephritis
Published: 2022-06-27 (Crawled : 23:00) - biospace.com/
KZR | $0.8016 -2.95% -3.04% 420K
|
Health Technology
|
| O: -1.99%
H: 2.96%
C: -2.36%
treatment sciences topline lupus life trial positive phase 2
Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
Published: 2022-04-15 (Crawled : 23:00) - biospace.com/
KZR | $0.8016 -2.95% -3.04% 420K
|
Health Technology
| Email alert
Add to watchlist
nasdaq grant
Kezar Appoints Courtney Wallace to its Board of Directors
Published: 2021-12-10 (Crawled : 13:00) - biospace.com/
KZR | $0.8016 -2.95% -3.04% 420K
|
Health Technology
|
| O: -3.93%
H: 0.0%
C: 0.0%
Kezar Life Sciences to Present at the Jefferies London Healthcare Conference
Published: 2021-11-11 (Crawled : 14:00) - biospace.com/
KZR | $0.8016 -2.95% -3.04% 420K
|
Health Technology
|
| O: 0.54%
H: 10.56%
C: 3.48%
life science conference
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.